Cheng‐Zhu Wu
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 6
- Pharmacology top 10%
- Microbial Natural Products and Biosynthesis 5
- Rehabilitation top 10%
- Magnolia and Illicium research 11
-
- Natural product bioactivities and synthesis 9
- Bioactive natural compounds 9
- Plant biochemistry and biosynthesis 4
- Heat shock proteins research 4
-
- Microbial Natural Products and Biosynthesis 5
-
- Oxidative Organic Chemistry Reactions 5
- Cited by
- ToxicologyPharmacologyRehabilitation
- Partner nations
- ChinaSouth KoreaAustralia
In The Last Decade
Cheng‐Zhu Wu
44 papers receiving 442 citations
Peers
Comparison fields: 5 of 73
- Toxicology 28
- Pharmacology 99
- Rehabilitation 38
- Molecular Biology 289
- Pharmacology 34
Countries citing papers authored by Cheng‐Zhu Wu
This map shows the geographic impact of Cheng‐Zhu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Zhu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Zhu Wu more than expected).
Fields of papers citing papers by Cheng‐Zhu Wu
This network shows the impact of papers produced by Cheng‐Zhu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Zhu Wu. The network helps show where Cheng‐Zhu Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cheng‐Zhu Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 10 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 2 | |
| 6 | 2020 | 4 | |
| 7 | 2020 | 3 | |
| 8 | 2019 | 12 | |
| 9 | 2018 | 11 | |
| 10 | 2017 | 4 | |
| 11 | 2017 | 12 | |
| 12 | 2016 | 7 | |
| 13 | 2016 | 29 | |
| 14 | 2016 | 41 | |
| 15 | [Transglycosylation of neolignans by enzymatic synthesis and evaluation of their antitumor activity]. | 2015 | 1 |
| 16 | 2015 | 10 | |
| 17 | 2015 | 11 | |
| 18 | 2014 | 30 | |
| 19 | 2014 | 12 | |
| 20 | 2009 | 38 |
About Cheng‐Zhu Wu
Cheng‐Zhu Wu is a scholar working on Toxicology, Rehabilitation and Molecular Biology, having authored 47 papers that have together received 446 indexed citations. Recurring topics across this work include Magnolia and Illicium research (11 papers), Natural product bioactivities and synthesis (9 papers), Bioactive natural compounds (9 papers), Bioactive Compounds and Antitumor Agents (6 papers), Microbial Natural Products and Biosynthesis (5 papers), Oxidative Organic Chemistry Reactions (5 papers), Plant biochemistry and biosynthesis (4 papers) and Heat shock proteins research (4 papers). The work is most often cited by research in Toxicology (28 citations), Pharmacology (99 citations) and Rehabilitation (38 citations). Cheng‐Zhu Wu has collaborated with scholars based in China, South Korea and Australia. Frequent co-authors include Qiang Huo, Young‐Soo Hong, Tao Ma, Hongmei Li, Mi‐Hee Woo, Jae‐Hyuk Jang, Jong Seog Ahn, Joong Su Kim, Meilin Zhu and Surong Zhao.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.